Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
If you are ready to make an appointment, select a button on the right.
If you have questions about MD Anderson’s appointment process, our
information page may be the best place to start.
Find information and resources for current and returning patients.
Learn about clinical trials at MD Anderson and search our database for open studies.
The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.
Your gift will help support our mission to end cancer and make a difference in the lives of our patients.
Our personalized portal helps you refer your patients and communicate with their MD Anderson care team.
As part of our mission to eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.
Choose from 12 allied health programs at School of Health Professions.
Learn about our graduate medical education residency and fellowship opportunities.
The B-Cell Lymphoma Moon Shot is revolutionizing the conventional medical research approach to rapidly translate findings into patient treatment options and develop personalized therapeutic strategies.
AJCC 6th Edition
Primary Tumor (T)
TX: Primary tumor cannot be assessed
T0: No evidence of primary tumor
Tis: Carcinoma in situ (DCIS, LCIS, Paget´s disease with no invasive tumor)
Invasive tumor measurement in greatest dimension
T1mic: Microinvasive <= 0.1 cm
T1a: >0.1 cm to 0.5 cm
T1b: >0.5 cm to 1 cm
T1c: >1 cm to 2 cm
T2: >2 cm to 5 cm
T3: >5 cm
Tumor of any size with direct extension to
T4a: Extension to chest wall, not including pectoralis muscle
T4b: Edema/peau d´orange or ulceration of the skin of the breast, or satellite skin nodules confined to the same breast
T4c: Both T4a and T4b
T4d: Inflammatory carcinoma
Regional (Ipsilateral) Lymph Nodes (N)
pNX: Cannot be assessed (e.g. previously removed, or not removed for pathologic study)
pN0: No regional lymph node metastasis histologically, no additional examination for ITC
Axillary lymph node metastasis (including axillary fat deposit and intramammary nodes)
Micrometastasis ( >0.2 mm to 2.0 mm)
1 to 3 axillary lymph nodes
4 to 9 axillary lymph nodes (at least 1 tumor deposit > 2.0 mm)
>= 10 axillary lymph nodes (at least 1 tumor deposit > 2.0 mm)
Distant Metastasis (M)
MX: Distant metastasis cannot be assessed
M0: No distant metastasis
M1: Distant metastasis